dc.contributor.author
Abras Feliu, Alba
dc.contributor.author
Ballart Ferrer, J. Cristina
dc.contributor.author
Llovet, Teresa
dc.contributor.author
Roig, Carme
dc.contributor.author
Miguélez Gutiérrez, Cristina
dc.contributor.author
Tebar, Silvia
dc.contributor.author
Berenguer, Pere
dc.contributor.author
Pinazo, Maria-Jesus
dc.contributor.author
Posada, Elizabeth
dc.contributor.author
Gascón i Brustenga, Joaquim
dc.contributor.author
Schijman, Alejandro G.
dc.contributor.author
Gállego Culleré, M. (Montserrat)
dc.contributor.author
Muñoz, Carmen
dc.date.issued
2018-05-08T13:25:49Z
dc.date.issued
2018-05-08T13:25:49Z
dc.date.issued
2018-04-17
dc.date.issued
2018-05-08T13:25:49Z
dc.identifier
https://hdl.handle.net/2445/122207
dc.description.abstract
Background: Polymerase chain reaction (PCR) has become a useful tool for the diagnosis of Trypanosoma cruzi infection. The development of automated DNA extraction methodologies and PCR systems is an important step toward the standardization of protocols in routine diagnosis.To date, there are only two commercially available Real-Time PCR assays for the routine laboratory detection of T. cruzi DNA in clinical samples: TCRUZIDNA.CE (Diagnostic Bioprobes Srl) and RealCycler CHAG (Progenie Molecular). Our aim was to evaluate the RealCycler CHAG assay taking into account the whole process. Methodology/Principal findings: We assessed the usefulness of an automated DNA extraction system based on magnetic particles (EZ1 Virus Mini Kit v2.0, Qiagen) combined with a commercially available Real- Time PCR assay targeting satellite DNA (SatDNA) of T. cruzi (RealCycler CHAG), a methodology used for routine diagnosis in our hospital. It was compared with a well-known strategy combining a commercial DNA isolation kit based on silica columns (High Pure PCR Template Preparation Kit, Roche Diagnostics) with an in-house Real-Time PCR targeting SatDNA. The results of the two methodologies were in almost perfect agreement, indicating they can be used interchangeably. However, when variations in protocol factors were applied (sample treatment, extraction method and Real-Time PCR), the results were less convincing. A comprehensive fine-tuning of the whole procedure is the key to successful results. Guanidine EDTA-blood (GEB) samples are not suitable for DNA extraction based on magnetic particles due to inhibition, at least when samples are not processed immediately. Conclusions/Significance: This is the first study to evaluate the RealCycler CHAG assay taking into account the overall process, including three variables (sample treatment, extraction method and Real-Time PCR). Our findings may contribute to the harmonization of protocols between laboratories and to a wider application of Real-Time PCR in molecular diagnostic laboratories associated with health centers.
dc.format
application/pdf
dc.publisher
Public Library of Science (PLoS)
dc.relation
Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0195738
dc.relation
PLoS One, 2018, vol. 13, num. 4, p. e0195738
dc.relation
https://doi.org/10.1371/journal.pone.0195738
dc.rights
cc-by (c) Abras, Alba et al., 2018
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)
dc.subject
Malalties parasitàries
dc.subject
Parasitic diseases
dc.title
Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: A comparative study of sample treatments, DNA extraction methods and real-time PCR assays
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion